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We have read with great interest the article by Kawaguchi et al.
[1]. The authors measured, in the operating room, the hepatic
concentrations of indocyanine green (ICG) to evaluate the func-
tion of congestive hepatic segments. Three groups of patients
were studied: partial hepatectomy, remnant liver of living
donors, and hepatic grafts of recipients. Although preoperative
three-dimensional computer tomography estimates the postop-
erative segment volumes, the function of congestive segments
is not evaluated by the imaging technique. Interestingly, the
authors showed that, following ICG injection, the dye concentra-
tions were signiﬁcantly lower in congestive than non-congestive
segments. ICG hepatic uptake rates were also decreased in the
congestive segments of the three groups of patients. However,
the concentrations of ICG and ICG hepatic uptake rates greatly
varied (between 10 and 80% of the values in non-congestive seg-
ments). Thus, some congestive segments conserve a near normal
function while others have a poor hepatic ICG uptake rate. Even
though peroperative ultrasonography detects anastomoses
between hepatic veins, favouring blood drainage from congestive
areas, the hepatic function of most congestive regions remain
unknown. The congestive segments with poor function decrease
the overall postoperative recovery, induce complications, and
slow hepatic regeneration. These segments can be treated by
hepatic venous reconstruction to better drain outﬂow. Interest-
ingly, congestive segments V have higher ICG uptake than seg-
ments VIII and these latter segments beneﬁt from hepatic vein
reconstruction more than segments V do. Thus, the use of a cam-
era with ﬂuorescence imaging in the operating room can estimate
the function of congestive segments and modify the surgical
procedures.
The reason why ICG concentrations were lower in congestive
segments was puzzling and the authors suggested that ICG ﬂow-
ing into sinusoids regurgitates back to portal veins without enter-
ing the extracellular space and without reaching hepatocytes. The
transport of ICG through hepatocytes might also be involved. ICG1. Hepatobiliary transport of the magnetic resonance (MR) contrast agent
OPTA. Livers were isolated from rats treated with saline (SAL, white squares)
onocrotaline to induce a sinusoidal obstruction syndrome (MCT, black
bols). Rats (n = 14) were studied either 4 days (black squares) or 18 days
ck circles) after MCT administration. Livers were perfused (non-recirculation
em) with a Krebs-Henseleit bicarbonate solution (0–10 min), Gd-BOPTA
lM, 10–40 min), and a Krebs-Henseleit bicarbonate solution (40–70 min). In
xperiments, the perfusate ﬂow rate was 30 ml/min. Gd-BOPTA was labelled
153Gd for measurements. (A) Bile ﬂow [in ll/min/g of liver] over time. (B)
atic concentrations of Gd-BOPTA [in nmol/g of liver] measured by a gamma
e placed over the livers. (C) Bile excretion rate of Gd-BOPTA [in nmol/min/g
ver]. Pharmacokinetic analysis estimates Gd-BOPTA uptake into hepatocytes
and Gd-BOPTA bile excretion (E). Modiﬁed from [4]. MCT rats had a lower
neration rates than normal rats after partial hepatectomy (70%).
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 access under CC BY-NC-ND license.enters human hepatocytes through the Organic Anion Transport-
ing Polypeptides B3 (OATP1B3) and Na(+)/Taurocholate Cotrans-
porting Polypeptide (NTCP) [2]. The dye is likely to exit without
transformation through the multiple resistance-associated pro-
tein 2 (MRP2).
The expression of human transporters was never investigated
in the congestive human hepatic segments described in the
study. However, a decreased hepatic uptake through OATP1B1/20
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B3 transporters has already been published in another chronic
congestive pathology of the liver, the sinusoidal obstruction syn-
drome. Thus, sinusoidal obstruction syndrome following chemo-
therapy is associated with blood stasis inside sinusoids and
patients with this syndrome have heterogenous hypointensities
(decreased uptake) at magnetic resonance imaging (MRI) after
injection of the hepatobiliary contrast agent Gd-EOB-DTPA [3].
In rats treated with monocrotaline (a toxic that induces sinusoi-
dal obtruction syndrome), the hepatic concentrations and bile
excretion of Gd-BOPTA are also lower than in control rats
(Fig. 1) [4]. Gd-BOPTA is another hepatobiliary contrast agent
close to Gd-EOB-DTPA that enters rat hepatocytes through rat
Oatps and is excreted into bile through the canalicular trans-
porter rat Mrp2 [5,6]. Interestingly, rats with sinusoidal obstruc-
tion syndrome have decreased regeneration rates following
partial hepatectomy (70%).
The study by Kawaguchi et al. [1] reinforces the growing
interest in hepatobiliary compounds that use the OATPs/MRP2
pathway through hepatocytes to evaluate the hepatic function
of patients. Dyes (ICG), MR contrast agents (Gd-BOPTA and
Gd-EOB-DTPA), and tracers (99mTc-mebrofenin) have been
evaluated and the results of these studies are summarized in
several recent reviews [7–9]. These articles describe how clear-
ance tests and liver imaging with hepatobiliary compounds
improve the scoring of hepatic function. Moreover, imaging
the entire liver with dyes, contrast agents, or tracers offers an
advantage over plasma biomakers since it studies all segments
of the liver [10]. However, as pointed out by the authors, trans-
port through this pathway does not represent all functions of
hepatocytes.
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Reply to: ‘‘Portal uptake function in veno-occlusive regions evaluated
by real-time ﬂuorescent imaging using indocyanine green’’
To the Editor:
We have read with interest the comments made by Kobbe et al.
to our recently published article, which demonstrated that portal
uptake of indocyanine green (ICG) in veno-occlusive regions
caused by dissection of the major hepatic veins decreased to
approximately 40% of that in non-veno-occlusive regions (rang-
ing from 10% to 80%) by using intraoperative ﬂuorescence imag-
ing [1]. In veno-occlusive hepatic regions, the portal veins can act
as drainage of arterial blood ﬂow, according to the severity of
venous occlusion. Thus, we hypothesized that, in hepatic regions
with severe venous occlusion, ICG ﬂowed into the sinusoids from
the hepatic arteries and portal veins following intravenous
administration, but regurgitated and drained into the portal sys-
tem before reaching the hepatocytes, leading to the decreased
concentration of ICG in the hepatic parenchyma. This should be
conﬁrmed in further studies by using in vivo ﬂuorescence micros-
copy [2], which may enable visualization of intrahepatic micro-
vascular blood ﬂow in the veno-occlusive regions.
Although the decreased portal uptake of ICG in the early
phase of the hepatic venous occlusion would be caused by the
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